Capital Performance Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,512
Closed -$11.5K 448
2024
Q3
$11.5K Buy
+1,512
New +$11.5K ﹤0.01% 786